Delving into the Latest Updates on Schweizerische Arbeitsgemeinschaft Für Klinische Krebsforschung with Synapse

Overview

Tags

Neoplasms

Skin and Musculoskeletal Diseases

Respiratory Diseases

Prophylactic vaccine

Recombinant vector vaccine

Fusion protein

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	2
Infectious Diseases	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Prophylactic vaccine	2
Recombinant vector vaccine	1
Fusion protein	1

Top 5 Target	Count

EGFR(Epidermal growth factor receptor erbB1)	1

Aim of this prospective randomized trial is to compare maintenance treatment with panobinostat interspersed with donor lymphocyte infusions (DLI) versus the standard approach of pre-emptive DLI alone in patients with poor-risk AML/MDS having favorably received an allogeneic HSCT followed by engraftment, donor chimerism and hematopoietic reconstitution.

Start Date24 Jul 2018

Sponsor / Collaborator

Johann Wolfgang Goethe-Universität Frankfurt am Main

[+2]

100 Clinical Results associated with Schweizerische Arbeitsgemeinschaft Für Klinische Krebsforschung

Login to view more data

0 Patents (Medical) associated with Schweizerische Arbeitsgemeinschaft Für Klinische Krebsforschung

Login to view more data

100 Deals associated with Schweizerische Arbeitsgemeinschaft Für Klinische Krebsforschung

Login to view more data

100 Translational Medicine associated with Schweizerische Arbeitsgemeinschaft Für Klinische Krebsforschung

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Aug 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

1

Phase 2

Phase 3

1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

BCG vaccine(Max Planck Institute For Infection Biology)	Pulmonary Tuberculosis More	Phase 3
Anti-EGFR-IL-dox(Schweizerische Arbeitsgemeinschaft Für Klinische Krebsforschung) ( EGFR )	Breast Cancer More	Phase 2
InCVAX	Solid tumor More	Phase 1